.png){kind=icon}
返回
Drug-target network
.png){kind=icon}
PRE
AI
DOI：10.1038/nbt1338.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
The global set of relationships between protein targets of all drugs and all disease-gene products in the human protein-protein interaction or 'interactome' network remains uncharacterized. We built a bipartite graph composed of US Food and Drug Administration-approved drugs and proteins linked by drug-target binary associations. The resulting network connects most drugs into a highly interlinked giant component, with strong local clustering of drugs of similar types according to Anatomical Therapeutic Chemical classification. Topological analyses of this network quantitatively showed an overabundance of 'follow-on' drugs, that is, drugs that target already targeted proteins. By including drugs currently under investigation, we identified a trend toward more functionally diverse targets improving polypharmacology. To analyze the relationships between drug targets and disease-gene products, we measured the shortest distance between both sets of proteins in current models of the human interactome network. Significant differences in distance were found between etiological and palliative drugs. A recent trend toward more rational drug design was observed.
Keyword:
HUMAN-DISEASE
DISCOVERY
EVOLUTION
RESOURCE
GENOME
GENES
BIOLOGY
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
41.7
论文数:
1.2W
被引数:
10.1W
机构
暂无机构信息
引用论文
.png){kind=icon}
Science and society - The impact of pharmacogenetics and pharmacogenomics on drug discovery科学与社会-药物遗传学和药物基因组学对药物发现的影响
PREAI
分享收藏分享收藏分享收藏
查看更多内容